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Introduction {#mcn12334-sec-0002}
============

More than 2 billion people globally are estimated to suffer from micronutrient deficiencies (von Grebmer *et al*. [2014](#mcn12334-bib-0001){ref-type="ref"}). Iron, zinc, vitamin A, iodine, folate and other vitamin B deficiencies are among the most widespread global micronutrient deficiencies (Muthayya *et al*. [2013](#mcn12334-bib-0002){ref-type="ref"}). Factors that contribute to poor micronutrient intake and absorption include poor dietary diversity, poor nutrient density of staple‐based complementary foods, anti‐nutritional factors in plant‐based foods and environmental enteropathy. Metabolic requirements for micronutrient are especially high during early development, pregnancy and lactation. Disease conditions resulting from infections can further aggravate micronutrient deficiencies (Katona & Katona‐Apte [2008](#mcn12334-bib-0003){ref-type="ref"}).

Strategies such as targeted supplementation with vitamin A, or universal salt iodization, oil fortification with vitamin A, or flour fortification with iron or folic acid, are often part of national strategies to address the problem of micronutrient malnutrition among vulnerable groups throughout the life cycle. Overcoming deficiencies of micronutrients can have a potential benefit in terms of young child survival, growth and development and preventing intrauterine growth restriction and low birth weight (Black *et al*. [2013](#mcn12334-bib-0004){ref-type="ref"}). Reviews such as the Copenhagen Consensus have consistently ranked micronutrients as the most cost‐effective development intervention (Copenhagen Consensus Panel [2012](#mcn12334-bib-0005){ref-type="ref"}). Economic analyses suggest that fortification and/or targeted supplementation with, for instance, iron, zinc, vitamin A, folic acid and iodine can be highly cost‐effective (Horton [2006](#mcn12334-bib-0006){ref-type="ref"}; Horton *et al*. [2008](#mcn12334-bib-0007){ref-type="ref"}; Edejer *et al*. [2005](#mcn12334-bib-0008){ref-type="ref"}; Yi *et al*. [2011](#mcn12334-bib-0009){ref-type="ref"}). Fortification will not reach all individuals but can be a cost‐effective strategy provided that a centrally processed, affordable fortified food vehicle is available and either the deficiency is widespread or only a small group is affected but the adverse effects because of the deficiency are very costly (Horton [2006](#mcn12334-bib-0006){ref-type="ref"}). Targeted micronutrient programs such as home fortification or periodic high‐dose supplements have the advantage to deliver micronutrients of concern to the vulnerable subpopulation(s) without unnecessarily exposing other groups in the population. In order for supplementation to be cost‐effective, the defined target group should be readily reached with little compliance issues (Horton [2006](#mcn12334-bib-0006){ref-type="ref"}).

When implementing micronutrient programs there is the risk of providing insufficient or excessive amounts, missing those at risk or redundant coverage (coverage of individuals with adequate intake, or coverage by more programs than necessary), potentially resulting in inadequate or excessive intakes and poor cost‐effectiveness. Designing an effective and safe fortification or supplementation program imposes the dual challenge of reaching the target population groups at most risk of micronutrient deficiency while avoiding overexposure of individuals at the high end of the intake distribution curves (European Food Safety Authority (EFSA) [2010](#mcn12334-bib-0010){ref-type="ref"}). This may pose particular challenges regarding micronutrient interventions that exert benefits in the target population but unintentionally adverse effects in a subgroup of this target population with already high intake or status of the micronutrient (e.g. 'targeted' vitamin A supplementation) (European Food Safety Authority (EFSA) [2010](#mcn12334-bib-0010){ref-type="ref"}). Increasing micronutrient intakes through universal fortification can deliver potential benefits to deficient population groups, but sometimes also risks in other population groups when consumed in excess (e.g. folic acid fortification to prevent neural tube defects in the unborn child versus masking of vitamin B12 deficiency in elderly) (European Food Safety Authority (EFSA) [2010](#mcn12334-bib-0010){ref-type="ref"}).

Values have been set for the intake of each micronutrient below which the risk for adverse health effects is likely to increase. The risk of an inadequate intake increases as an individual\'s intake falls further below the recommended intake (Food and Nutrition Board & Institute of Medicine (IOM) [2000](#mcn12334-bib-0011){ref-type="ref"}). At two standard deviations below the recommended intake, i.e. the estimated average requirement (EAR), the risk is approximately 50% that an individual\'s requirements are not met. Adverse health consequences because of a micronutrient deficiency condition increase in incidence and/or severity the further the usual intake falls below the EAR (Renwick *et al*. [2004](#mcn12334-bib-0012){ref-type="ref"}). Therefore, reducing the number of individuals with inadequate micronutrient intakes can be expected to have clear benefits on micronutrient deficiency‐related morbidity especially when the morbidity is severe and/or chronic.

However, the adverse health consequences of deficiency are far better understood than the evidence base related to the consequences of excess, if any. The 'excess' level of intake is neither well understood and defined for many micronutrients, nor do biomarkers exist that can detect early adverse effects. Considerable uncertainty exists for many micronutrients about the 'threshold' for intake or a biomarker, above which the risk of adverse effects may increase and the dose--response relationship (Renwick *et al*. [2004](#mcn12334-bib-0012){ref-type="ref"}). The tolerable upper intake level (UL) is the highest daily intake still considered to be safe for almost all healthy individuals in a specified group. Depending on the magnitude of the evidence, the UL is obtained by downward adjustment of the no‐observed‐adverse‐effect level (if known) or the lowest‐observed‐adverse‐effect level by applying an uncertainty factor. This has resulted for a number of micronutrients in an UL that is close to the recommended nutrient intake because of large uncertainty factors used to set this UL (European Commission [2006](#mcn12334-bib-0013){ref-type="ref"}). For some micronutrients, no evidence of risk of adverse effects is established, and hence no safe tolerable upper intake level (UL) is defined (i.e. biotin, pantothenic acid, chromium, vitamin B1, B2, B12 and K). For other micronutrients, the risk of exceeding the UL is low (i.e. vitamin B6, C, D and E, niacin, molybdenum, phosphorus and selenium). For some micronutrients, a potential risk of exceeding the maximum safe UL exists (i.e. vitamin A as preformed retinol, zinc, iron, iodine, copper and calcium). For the latter micronutrients, programs should be cautiously designed and monitored to ensure 'at risk' population groups are reached without any appreciable risk of adverse effects in subgroups that consume high amounts of the micronutrient.

Important elements of the program cycle include the gathering of information to assess the nutrition situation, development of a national policy and strategy, program design, implementation and monitoring, review and evaluation, and adjustment if necessary. Before implementing a micronutrient program it is critical to assess the nutrition situation by collecting data among the different population groups that can be referred to as the 'ABCD' of nutrition assessment; anthropometric assessments, biomarker or biochemical assessments, clinical assessments (morbidity and mortality) and dietary assessment. These data allow understanding the magnitude of the health problem and the vulnerable population group(s) at risk of micronutrient deficiency. Information on food and micronutrient intake distribution in the different population groups will help predict how micronutrient interventions will work in a variety of contexts. Another critical element in planning (cost) effective and safe programs is the ongoing monitoring and evaluation of the nutrition situation through collection of data. It provides an indication of the effectiveness and safety of the intervention and allows adjusting the type of intervention, amount of provided micronutrients or geographic distribution, if needed. Some countries have implemented one or multiple programs, focusing mostly on vitamin A, iodine and iron. However, availability of data on biomarkers predictive of nutrient intake, status and adverse health effects (Combs *et al*. [2013](#mcn12334-bib-0014){ref-type="ref"}; Raiten & Combs [2015](#mcn12334-bib-0015){ref-type="ref"}) is still sparse, and few countries have conducted detailed nutrition surveys, as their collection can be time and resource‐intensive. Often multiple programs with micronutrients are implemented to reach a greater proportion of the at‐risk population. In particular, implementation of multiple micronutrient interventions requires coordination and monitoring to ensure that these programs are complementary and not overlapping, which may result in unnecessarily exposure of vulnerable groups. Collecting dietary intake data and biomarkers can be used to correct program designs to ensure that intake ranges in the different life‐stage groups are effective and safe. Dietary intake data can be used in software modelling to predict the shift in micronutrient adequacy in different population groups for a selected food vehicle and fortification level.

The need for data modelling to predict efficacy and safety in micronutrient programs {#mcn12334-sec-0003}
------------------------------------------------------------------------------------

Until recently, dietary intake modelling tools were not able to predict the effect of intake from combined fortification and supplementation programs. As addressed in this symposium report, a new simulation approach allows to predict the effect of implementing fortification combined with supplementation on intakes below the EAR and above the UL and related program cost versus the savings (Engle‐Stone *et al*. [2015](#mcn12334-bib-0016){ref-type="ref"}). Other software tools have been developed that simulate the effect of changing food or nutrient intakes on prevention of the related burden of disease (i.e. the benefits). In risk--benefit approaches, the same principle is used to assess both the preventable burden of disease and the risks related to 'excessive' food or nutrient intake, provided that sufficient evidence is available to simulate the adverse health response. In order to use a risk--benefit approach, a better understanding is needed of the relation between micronutrient intake, status and morbidity/mortality outcomes. For some micronutrients the link between micronutrient intake, status and morbidity/mortality is sufficiently established to predict health benefits when overcoming its deficiency (Horton [2006](#mcn12334-bib-0006){ref-type="ref"}). However, with the current dearth of data in many countries on micronutrient intake, status and related disease incidence, program modelling to predict the benefits, and even more so the risks, is still a challenge. It is nevertheless encouraging that in many countries the collection of nutrition data is increasing, which will further help program planners and policy‐makers to design cost‐effective and safe micronutrient interventions.

Inter‐individual variations and micronutrient interactions {#mcn12334-sec-0004}
----------------------------------------------------------

Minimum and maximum intake values for micronutrients are relevant for population groups, but do not necessarily reflect adequate or safe intake values for all individuals in that group. The requirement and safety limit for a micronutrient not only varies by age, gender and life‐stage, but also by health condition, medication use and genetic profile, making it even more challenging to develop a safe and effective program tailored to all 'at risk' individuals. For instance, chronic disease conditions or genetic polymorphisms may lead to higher micronutrient requirements. Micronutrients do not necessarily provide benefits in all deficiency conditions; complex interactions may exist between the delivered micronutrients, micronutrient status, infections and medication use. Complicating factors include (1) interactions between micronutrients, for instance iron and zinc reducing each other\'s absorption (Lönnerdal [2004](#mcn12334-bib-0017){ref-type="ref"}), (2) micronutrient--drug interactions; micronutrients reducing the absorption or efficacy of a drug or *vice versa* (Scaglione & Panzavolta [2014](#mcn12334-bib-0018){ref-type="ref"}; Hathcock [1985](#mcn12334-bib-0019){ref-type="ref"}), or (3) antagonistic interactions between micronutrients and infections (e.g. iron and malaria). The benefits and risks of some micronutrients therefore depend on the setting in which they are provided. For instance, the effect of certain micronutrients may not only depend on whether the target population is deficient or not, but also on whether malaria control strategies are implemented in malaria endemic regions. This is exemplified by the Pemba study, in which children living on malaria‐endemic Pemba island who received iron and folic acid supplements, were more likely to die or need treatment in hospital for an adverse event (Sazawal *et al*. [2006](#mcn12334-bib-0020){ref-type="ref"}). However, in a sub‐study of the trial in which children were given malaria‐reduction measures, children who were iron deficient and anaemic at baseline, showed a significant reduction in adverse events, including malaria episodes, suggesting that supplementation with iron and folic acid may especially confer benefits to those who are deficient.

These issues, altogether, pose a challenge to program planners in designing micronutrient intervention programs that meet the requirements of the majority of the population at risk while still being safe. There is a need for tools that assist is designing micronutrient intervention programs that are *effective* in reaching the target groups at risk of developing micronutrient deficiencies, *efficient*, in terms of reaching the target group and not unnecessarily exposing non‐target groups, and *safe*, in terms of not overexposing a segment of the population that is already more than adequate, especially vulnerable target groups. There is a need to understand how specific micronutrients, mainly as folic acid and iron, may interact with medication and infection, and how they exert beneficial or antagonistic effects under these conditions. This raises the question of how to achieve the maximum possible public health benefits of a micronutrient intervention strategy with the least risks.

###### Key messages

Monitoring of data (dietary intake, program coverage, biomarkers and morbidity) among vulnerable population groups is essential to optimize effectiveness, safety, and efficiency of micronutrient programs.Modelling tools are needed that predict the effectiveness, safety, and efficiency of micronutrient programs by integrating above data.Research is needed to identify biomarkers predictive of micronutrient exposure, status, and potential health consequences of inadequate and especially excessive micronutrient exposure. This may help setting the appropriate no‐observed‐adverse‐effect or lowest‐adverse‐effect level, currently often based on scant data, particularly for young children.More insight is needed into the antagonistic effects resulting from complex interactions between micronutrients, drugs, and infections.

Objective {#mcn12334-sec-0005}
=========

During the Global Summit on Food Fortification on 9--11 September 2015 in Arusha, one of the sessions included a special session co‐organized by Sight and Life and UNICEF, entitled 'Effective and Safe Micronutrient Interventions: Weighing the Risks against the Benefits'. The aim of the session was to identify existing tools and needs to assist policy makers in designing effective micronutrient programs with the highest public health benefits and least risks. The presentations in the session addressed this challenge, based on a number of case studies related to folic acid, iodine and vitamin A.

Session summary {#mcn12334-sec-0006}
===============

An introduction to the session was given by *Dr*. *Maaike Bruins* (DSM Biotechnology Center, Delft, the Netherlands), with the title 'Assessing the risks and benefits of micronutrients interventions'. In order to understand the risks of inadequate and excessive intake of a micronutrient, information is required on the intake distribution of the micronutrient in the population. This enables to assess the proportion of a population life‐stage group with intakes below their requirements and above their UL. Software is available, such as PC‐SIDE and IMAPP, for the estimation and modelling of food and micronutrient intake distributions, which can assist in selecting optimal food vehicles and fortification levels (Iowa State University [2015](#mcn12334-bib-0021){ref-type="ref"}). Other tools make it possible to estimate the preventable public disease burden because of a micronutrient intervention program, expressed for instance as preventable disability‐adjusted life years (DALYs). The DALY is a quantitative measure of overall disease burden and can serve as important guide to decision‐making. The DALY is expressed as the number of years lost because of early death or morbidity (e.g. infections, anaemia, motor and cognitive impairments, or blindness). The DALY metric is composed of mortality and incidence, duration and disability of the morbidity (related to micronutrient deficiency). For instance, preventing DALYs by overcoming maternal folate deficiency may have a large public health impact; the preventable lifelong and severe disabilities resulting from of neural tube defects are substantial, even if a few neural tube defects in 1000 births could be prevented. The World Health Organization (WHO) has developed a source of estimates for cost‐effectiveness of micronutrient interventions is the CHOosing Interventions that are Cost Effective (WHO‐CHOICE) database (World Health Organization (WHO) [2016](#mcn12334-bib-0023){ref-type="ref"}). The estimates are based on known intervention costs and effectiveness (in terms of micronutrient status), and links between micronutrient status and morbidity/mortality outcomes. The WHO has also developed tools that can assist program planners in simulating the public health impact of an increase in micronutrient intake in terms of DALYs gained ([World Health Organization (WHO) 2015](#mcn12334-bib-0022){ref-type="ref"}). This requires (1) dietary intake data in different population groups and (2) evidence for a dose--response relationship between micronutrient intake and morbidity because of deficiency. With the introduction of a micronutrient intervention, the benefits of increasing micronutrients do not always clearly outweigh the risks. For instance, when implementing mandatory fortification, the benefits of preventing frequent, or severe, or life‐long disabilities should be balanced against the possible risks of excess intake in other population groups (Hoekstra *et al*. [2008](#mcn12334-bib-0024){ref-type="ref"}). Risk--benefit assessment software provides the option to quantify the public health risks and benefits, and balance them, using for instance DALYs as a common metric (Ellis & Aspurger [2000](#mcn12334-bib-0025){ref-type="ref"}). Even though simulating changes in DALYs resulting from micronutrient intervention programs can provide useful information to policy makers to set investment priorities, the required dietary intake data are often lacking. Moreover, for many micronutrients the dose--response relationship between excessive intake and risks is not well known. Even though simulating changes in DALYs resulting from micronutrient intervention programs can provide useful information to policy makers to set investment priorities, the required intake data are often lacking and the methods require in‐depth expertise. Next to these sophisticated modelling tools, more user‐friendly tools are needed that integrate information on program coverage, dietary intake distribution, biomarkers and morbidity to design effective and safe micronutrient programs in terms of public health impact.

Increasing micronutrient intake may confer benefits on those who have inadequate intakes. However, micronutrient interventions may not confer benefits in all settings. For instance, in some studies iron supplementation has been associated with an increased risk of malaria and death in children living in malaria‐endemic regions, but not when regular malaria surveillance and treatment services are provided ([World Health Organization (WHO) 2015](#mcn12334-bib-0026){ref-type="ref"}). Another example of a micronutrient that may not necessarily confer benefits under all circumstances is, for instance, folic acid. Folic acid supplementation may be beneficial to the folate‐deficient child, but may confer risks when high‐dose supplements are implemented in malaria‐endemic settings alongside antimalarial drugs (Kupka [2015](#mcn12334-bib-0027){ref-type="ref"}). This was discussed by *Dr*. *Roland Kupka from UNICEF* (*New York*). The WHO calls for micronutrient powder (MNP) programs to be implemented alongside malaria control strategies in malaria endemic regions. Current MNP formulations generally provide folic acid and other micronutrients at the Recommended Nutrient Intake level. However, the benefits and risks of providing supplemental folic acid are largely unknown. The limited data available suggest that folate deficiency may not be a major public health problem among children living in sub‐Saharan Africa; as a result, supplemental folic acid may not confer health benefits. Furthermore, folic acid provided at supraphysiological, and possibly even physiological, levels may favour the growth of the parasite *Plasmodium falciparum* (responsible for 85% of malaria cases), inhibit clearance of the parasite by sulphadoxine‐pyrimethamine (SP)‐treated malaria and increase subsequent recrudescence (Nzila *et al*. [2014](#mcn12334-bib-0028){ref-type="ref"}). Limiting prophylactic SP use or promoting the use of insecticide‐treated bed nets may render the use of folic acid in MNP programs safer, but programmatic barriers to these approaches may remain. The use of 5‐methyltetrahydrofolic acid concomitantly with SP may be a promising alternative, as it does not affect SP efficacy, although its stability in food and cost‐in‐use remain to be confirmed (Scaglione & Panzavolta [2014](#mcn12334-bib-0018){ref-type="ref"}). The presentation concluded that more work is needed to characterize the prevalence of folate deficiency among young children worldwide, and to optimize the benefit--risk ratio of MNP programs in sub‐Saharan Africa.

Both iodine deficiency and iodine excess have adverse health effects. *Prof*. *Michael Zimmerman from the ETH Zürich* (*Switzerland*) discussed the risks and benefits of salt iodization programs. In general, the relatively small risks of iodine excess are far outweighed by the substantial risks of iodine deficiency (Zimmermann [2008](#mcn12334-bib-0029){ref-type="ref"}). Iodine deficiency has multiple adverse effects on growth and development because of inadequate thyroid hormone production, which are termed the iodine deficiency disorders (IDD). IDD remains one of the most common causes of preventable mental impairment worldwide. In nearly all iodine‐deficient countries, the best strategy to control IDD is salt iodization, one of the most cost‐effective ways of contributing to economic and social development (Zimmermann [2008](#mcn12334-bib-0029){ref-type="ref"}). In areas of severe iodine deficiency, iodine repletion in pregnant women improves pregnancy outcomes, eliminates endemic cretinism and improves IQ in their children. Iodine repletion in newborns reduces infant mortality, and may improve cognitive development and growth. Even in areas of mild‐to‐moderate iodine deficiency, repletion in school‐aged children improves cognition and fine motor skills (Zimmermann [2007](#mcn12334-bib-0030){ref-type="ref"}). On the other hand, the introduction of iodized salt to regions with chronic IDD may transiently increase the incidence of thyroid disorders, such as iodine‐induced hyperthyroidism and autoimmune hypothyroidism, and programs should therefore include monitoring for both iodine deficiency and excess. More data on the epidemiology of thyroid disorders caused by differences in iodine intake are needed, and should be the focus of future research.

The adverse effects of vitamin A deficiency include childhood blindness, and the increased risk of mortality from measles and diarrhoea (Stevens *et al*. [2015](#mcn12334-bib-0031){ref-type="ref"}). Vitamin A supplementation and fortification programs can be a cheap and effective way to reduce morbidity and mortality because of vitamin A deficiency (Horton [2006](#mcn12334-bib-0006){ref-type="ref"}). These programs have significantly improved millions of lives among pre‐school children in many parts of the world (Stevens *et al*. [2015](#mcn12334-bib-0031){ref-type="ref"}). Long‐term excessive vitamin A intakes, on the other hand, can lead to adverse effects, such as hepatotoxicity. Generally, the substantial risks of vitamin A deficiency can be expected to far outweigh the relatively small risks of vitamin A excess (Allen & Haskell [2002](#mcn12334-bib-0032){ref-type="ref"}). The lack of coordination of multiple vitamin A interventions and many overlapping schemes in some areas has increased concern about the risks of these programs, as some children could theoretically receive well above their recommended daily dose of the vitamin. The uncertainty around the level of excess for vitamin A has resulted in a small margin of safe intake for young children, between the recommended intake levels and maximum safe UL 'thresholds' (Allen & Haskell [2002](#mcn12334-bib-0032){ref-type="ref"}). *Dr*. *Georg Lietz from Newcastle University* (*Newcastle upon Tyne*, *UK*) discussed how to best assess the window of benefit for vitamin A intake. In his presentation, *Dr*. *Lietz* highlighted the need for reliable, robust and affordable biomarkers of inadequate and excess status, to enable policy and program makers to adjust the correct level and coverage of their interventions. The appropriate no‐observed‐adverse‐effect level or the lowest‐observed‐adverse‐effect level for children up to 5 years of age needs to be urgently determined and the ULs revised as most ULs for children are extrapolated from ULs for adults. *Dr*. *Lietz* also discussed the benefits and problems associated with the most recent methods to have been developed to enable the monitoring of both fortification and supplementation programs, including the application of stable isotope dilution techniques, and the potential for lab‐on‐chip technologies for future monitoring. He ended his presentation by highlighting the need to coordinate different methods of risk assessment, to make the monitoring process more efficient, reliable and cost‐effective.

*Dr*. *Reina Engle‐Stone from the University of California* (*Davis*, *CA*, *USA*) presented a dietary modelling approach to assess the risk of inadequate and excessive intakes under different program scenarios, and their applications to program planning. Her presentation provided an overview of the methodology for the use of dietary data to examine the risk of inadequate and excessive micronutrient intakes using dietary reference values, and given information on current dietary patterns and the reach of program delivery platforms. Examples from Cameroon illustrated the use of dietary modelling to set fortification levels, by predicting the effects of each new or modified program on dietary intake (Engle‐Stone *et al*. [2015](#mcn12334-bib-0016){ref-type="ref"}; Brown *et al*. [2015](#mcn12334-bib-0033){ref-type="ref"}; Kagin *et al*. [2015](#mcn12334-bib-0034){ref-type="ref"}; Vosti *et al*. [2015](#mcn12334-bib-0035){ref-type="ref"}). This dietary modelling tool can be used to predict the effect of fortification of different food vehicles and overlapping micronutrient programs on the percentage of the population with intakes below EAR or above the UL (Brown *et al*. [2015](#mcn12334-bib-0033){ref-type="ref"}; Vosti *et al*. [2015](#mcn12334-bib-0035){ref-type="ref"}). Finally, the role of complementary modelling tools was discussed, including the (1) Lives Saved Tool (LiST), which predicts the mortality reduction from some micronutrient interventions delivered to mothers and children (Johns Hopkins School of Public Health [2015](#mcn12334-bib-0036){ref-type="ref"}), (2) models assessing liver vitamin A concentration, which can assist in the interpretation of risk of dietary intakes above the upper intake level in young children, and (3) program coverage surveys which reveal absent or redundant program coverage and thus help identify subpopulations (e.g. regions) at risk of inadequate or excessive intake (Aaron [2014](#mcn12334-bib-0037){ref-type="ref"}; Spohrer [2015](#mcn12334-bib-0038){ref-type="ref"}).

Population dietary intake data can be used to model the effect of different food vehicles and micronutrient levels to optimize coverage and minimize the risks of inadequate and excessive intakes in relation to dietary cut‐off points. Monitoring intake data will enable policy makers to adjust to the correct food vehicle, micronutrient level, and coverage of intervention programs. However, the success of these programs has, inevitably, to be confirmed by applying biomarkers indicative of micronutrient status that are affordable, sensitive and specific, and can be applied in population settings (Combs *et al*. [2013](#mcn12334-bib-0014){ref-type="ref"}; Raiten & Combs [2015](#mcn12334-bib-0015){ref-type="ref"}). Some methods which are currently applied are inadequate, because of their lack of precision and accuracy, to detect nutrient concentrations in at‐risk population groups, or because of insensitivity to changes in status within a certain range (e.g. serum retinol), or alterations during inflammation (zinc, retinol, ferritin). Thus, improved biomarkers are urgently needed which will enable policy makers to understand the benefits and risks in vulnerable population groups related to increasing micronutrient intakes. Tools are available which assess or predict the effects of micronutrient programs, in terms of dietary intakes against dietary cut‐off points. However, there is still need for standardized, user‐friendly tools, which predict the public health impact made by micronutrient interventions, by integrating benefits and possible risk. More research is warranted in order to understand the concerns regarding the safety of iron and folic acid supplementation among young children in malaria endemic areas, and their interaction with antimalarials and infections. Research is needed to assess the minimum and maximum intake range for vitamin A outside which intakes might cause concern. In general, the small risks of micronutrient excess are far outweighed by the substantial benefits of overcoming the deficiency. However, there is an urgent need to monitor overlapping micronutrient supplementation and fortification programs, and to evaluate the benefits and risks (if any) of increasing population micronutrient intakes for each setting (population group, region, choice of food vehicle, micronutrient level in food, micronutrient status of the population group, concomitant food and medications, etc.).
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